ARCH Venture Management, LLC Q1 2025 Filing
Filed May 15, 2025
Portfolio Value
$206.2B
Holdings
9
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (9 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | BEAMBEAM THERAPEUTICS INC. | 4,540,132 | $88.7B | 43.00% | |
| 2 | MAZEMAZE THERAPEUTICS, INC. | 4,120,053 | $45.4B | 22.00% | |
| 3 | RAPPRAPPORT THERAPEUTICS, INC. | 3,728,738 | $37.5B | 18.21% | |
| 4 | ERASERASCA, INC. | 11,055,554 | $15.1B | 7.34% | |
| 5 | VERVVERVE THERAPEUTICS, INC. | 2,008,809 | $9.1B | 4.42% | |
| 6 | GOSSGOSSAMER BIO, INC. | 8,055,916 | $8.8B | 4.26% | |
| 7 | UNBXUNITY BIOTECHNOLOGY, INC. | 1,004,817 | $1.0B | 0.51% | |
| 8 | QTTBQ32 BIO INC. | 320,482 | $532.0M | 0.26% | |
| 9 | CEROCERO THERAPEUTICS HOLDINGS, INC. | 22,102 | $16.1M | 0.01% |